or
forgot password

    • cancer clinical trials in livingston, NJ

    • Combination Chemotherapy in Treating Children With Progressive Brain Tumors
    St. Barnabas Medical Center Cancer Center
    Livingston, New Jersey 07039
    Brain and Central Nervous System Tumors
    Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer
    St. Barnabas Medical Center
    Livingston, New Jersey 07039
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer
    St. Barnabas Medical Center
    Livingston, New Jersey 07039
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    St. Barnabas Medical Center
    Livingston, New Jersey 07039
    Breast Cancer
    Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
    St. Barnabas Medical Center
    Livingston, New Jersey 07039
    Neuroblastoma
    Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome
    St. Barnabas Medical Center
    Livingston, New Jersey 07039
    Hemolytic Uremic Syndrome
    Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
    St. Barnabas Medical Center
    Livingston, New Jersey 07039
    Prostate Cancer
    Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
    St. Barnabas Medical Center
    Livingston, New Jersey 07039
    Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Retinoblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma
    St. Barnabas Medical Center
    Livingston, New Jersey 07039
    Lymphoma
    Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer
    Cancer Center at Saint Barnabas Medical Center
    Livingston, New Jersey 07039
    Carcinoma, Metastatic Breast
    PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)
    Pfizer Investigational Site
    Livingston, New Jersey 07039
    Melanoma, Breast Neoplasms, Carcinoma, Renal Cell, Lymphoma, T-Cell, Carcinoma, Non-Small-Cell Lung
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    St. Barnabas Cancer Center
    Livingston, New Jersey 07039
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
    St. Barnabas Cancer Center
    Livingston, New Jersey 07039
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma
    Pfizer Investigational Site
    Livingston, New Jersey 07039
    Carcinoma, Renal Cell, Kidney Neoplasms
    Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
    St. Barnabas Medical Center
    Livingston, New Jersey 07039
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor
    Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
    St. Barnabas Medical Center Cancer Center
    Livingston, New Jersey 07039
    Lymphoma
    Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
    Pfizer Investigational Site
    Livingston, New Jersey 07039
    Colorectal Neoplasms
    Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)
    Pfizer Investigational Site
    Livingston, New Jersey 07039
    Lymphoma
    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
    St. Barnabas Medical Center Cancer Center
    Livingston, New Jersey 07039
    Breast Cancer
    Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
    Pfizer Investigational Site
    Livingston, New Jersey 07039
    Osteoporosis
    Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer
    Saint Barnabas Medical Center
    Livingston, New Jersey 07039
    Breast Neoplasms, Neoplasm Metastasis
    Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
    Saint Barnabas Medical Center
    Livingston, New Jersey 07039
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    St. Barnabas Medical Center Cancer Center
    Livingston, New Jersey 07039
    Brain and Central Nervous System Tumors
    Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Livingston, New Jersey 07039
    Carcinoma, Non-Small Cell Lung
    Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer
    Pfizer Investigational Site
    Livingston, New Jersey 07039
    Carcinoma, Non-Small-Cell Lung
    Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery
    St. Barnabas Medical Center Cancer Center
    Livingston, New Jersey 07039
    Colorectal Cancer
    Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases
    Pfizer Investigational Site
    Livingston, New Jersey 07039
    Non-Small Cell Lung Cancer
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    Saint Barnabas Medical Center
    Livingston, New Jersey 07039
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Expanded Access Program for Maraviroc At Multiple Centers
    Pfizer Investigational Site
    Livingston, New Jersey 07039
    Advanced HIV Infection
    A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.
    Pfizer Investigational Site
    Livingston, New Jersey 07039
    Neoplasms
    Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer
    Pfizer Investigational Site
    Livingston, New Jersey 07039
    Colorectal Neoplasms
    A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer
    St. Barnabas Medical Center
    Livingston, New Jersey 07039
    Prostate Cancer
    Follow-Up Study for Exubera
    Pfizer Investigational Site
    Livingston, New Jersey 07039
    Diabetes Mellitus
    Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer
    Pfizer Investigational Site
    Livingston, New Jersey 07039
    Advanced Breast Cancer
    Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis
    Pfizer Investigational Site
    Livingston, New Jersey 07039
    Menopause, Osteoporosis
    Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma
    Pfizer Investigational Site
    Livingston, New Jersey 07039
    Lymphoma, B-Cell